Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The histone transmethylase complex comprising
WD repeat domain 77
(
WDR77
) and protein arginine methyltransferase 5 (PRMT5) catalyzes dimethylation of H4R3 (H4R3me2) and drives cancer cell proliferation and migration, but its regulation is not fully understood. Here, we report that sirtuin 7 (SIRT7) directly deacetylates
WDR77
and that this deacetylation interferes with the
WDR77
-PRMT5 interaction and suppresses proliferation of human
colon cancer
HCT116 cells. Using co-expression in HEK293T cells and co-immunoprecipitation assays, we observed that SIRT7 deacetylates
WDR77
at Lys-3 and Lys-243, which reduced of
WDR77
's interaction with PRMT5. More importantly, this reduction suppressed the transmethylase activity of the
WDR77
/PRMT5 complex, resulting in a reduction of the H4R3me2 modification. Rescue of the
WDR77
-KO HCT116 cells with a
WDR77
-2KR (K3R and K243R) variant yielded cell migration and proliferation rates that were significantly lower than those of
WDR77
-KO HCT116 cells rescued with WT
WDR77
. In summary, SIRT7 is a major deacetylase for
WDR77
, and SIRT7-mediated deacetylation of
WDR77
at Lys-3 and Lys-243 weakens the
WDR77
-PRMT5 interaction and activity and thereby suppresses growth of cancer cells.
...
PMID:Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity. 3028 1